The potential roles of nanobiomaterials in distraction osteogenesis.

Distraction osteogenesis (DO) technique is used worldwide to treat many orthopedic conditions. Although successful, one limitation of this technique is the extended period of fixators until the bone is consolidated. The application of growth factors (GFs) is one promising approach to accelerate bone regeneration during DO. Despite promising in vivo results, its use is still limited in the clinic. This is secondary to inherent limitations of these GFs. Therefore, a development of delivery systems that allow sustained sequential release is necessary. Nanoparticles and nanocomposites have prevailing properties that can overcome the limitations of the current delivery systems. In addition, their use can overcome the current challenges associated with the insufficient mechanical properties of scaffolds and suboptimal osteogenic differentiation of transplanted cells in the distraction gap. We discuss the clinical implications, and potential early applications of the nanoparticles and nanocomposites for developing new treatments to accelerate bone regeneration in DO.

[1]  D. Graves,et al.  Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis , 2008, Journal of dental research.

[2]  J. Aronson,et al.  Immunohistochemical Study of Osteopontin Expression During Distraction Osteogenesis in the Rat , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  M. Tabrizian,et al.  Distraction Osteogenesis and Its Challenges in Bone Regeneration , 2012 .

[4]  L. Meinel,et al.  Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Rui L. Reis,et al.  Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. , 2009, Biomaterials.

[6]  J. Henderson VEGF-Activated Angiogenesis During Bone Regeneration , 2007 .

[7]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[8]  S. Filip,et al.  The role of mesenchymal stem cells in bone repair and regeneration , 2014, European Journal of Orthopaedic Surgery & Traumatology.

[9]  Robert Langer,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[10]  J. Au,et al.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. , 2012, Advanced drug delivery reviews.

[11]  K. Weise,et al.  Growth factors in distraction osteogenesis , 1999, International Orthopaedics.

[12]  R. Reis,et al.  Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration , 2010, Journal of materials science. Materials in medicine.

[13]  M. Tabrizian,et al.  Modulated release of OP-1 and enhanced preosteoblast differentiation using a core-shell nanoparticulate system. , 2009, Journal of biomedical materials research. Part A.

[14]  Sha Jin,et al.  Nanoparticle-mediated gene delivery. , 2009, Methods in molecular biology.

[15]  Barrett E. Rabinow,et al.  Nanosuspensions in drug delivery , 2004, Nature Reviews Drug Discovery.

[16]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[17]  H. Oxlund,et al.  Local injection of TGF-β increases the strength of tibial fractures in the rat , 1994 .

[18]  H. Oxlund,et al.  Local injection of TGF-beta increases the strength of tibial fractures in the rat. , 1994, Acta orthopaedica Scandinavica.

[19]  F. Cui,et al.  Application of nerve growth factor by gel increases formation of bone in mandibular distraction osteogenesis in rabbits. , 2010, The British journal of oral & maxillofacial surgery.

[20]  K. Fung,et al.  Sustained expression of transforming growth factor-beta1 by distraction during distraction osteogenesis. , 2002, Life sciences.

[21]  Wei Tang,et al.  Effects of bone morphogenetic protein 2 gene therapy on new bone formation during mandibular distraction osteogenesis at rapid rate in rabbits. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[22]  Michael S. Goldberg,et al.  Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[23]  Jing Hu,et al.  Temporospatial expression of vascular endothelial growth factor and basic fibroblast growth factor during mandibular distraction osteogenesis. , 2003, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[24]  Kozo Nakamura,et al.  Effect of Vascularity on Canine Distracted Tibial Callus Consolidation , 2005, Clinical orthopaedics and related research.

[25]  Thomas J Webster,et al.  Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. , 2006, Journal of nanoscience and nanotechnology.

[26]  D. Moore,et al.  Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. , 2009, The Journal of bone and joint surgery. American volume.

[27]  Thomas Rades,et al.  Lipid based particulate formulations for the delivery of antigen , 2005, Immunology and cell biology.

[28]  B. Heng,et al.  Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems , 2008, Scandinavian journal of clinical and laboratory investigation.

[29]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.

[30]  I. Hvid,et al.  Periosteal insulin-like growth factor I and bone formation. Changes during tibial lengthening in rabbits. , 1996, Acta orthopaedica Scandinavica.

[31]  S. Richardson,et al.  Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells , 2008, Arthritis research & therapy.

[32]  R. Hamdy,et al.  The role of growth factors on acceleration of bone regeneration during distraction osteogenesis. , 2013, Tissue engineering. Part B, Reviews.

[33]  C. Laurencin,et al.  Bone tissue engineering by gene delivery. , 2006, Advanced drug delivery reviews.

[34]  Tae Gwan Park,et al.  Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. , 2007, Advanced drug delivery reviews.

[35]  J. Fisher,et al.  Nanoparticle technology in bone tissue engineering , 2007, Journal of drug targeting.

[36]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering , 2009, Biotechnology Letters.

[37]  M. Hussain,et al.  Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. , 2007, Biomaterials.

[38]  J. Fernandes,et al.  Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  K. Harada,et al.  Effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone consolidation on distraction osteogenesis: a preliminary study in rabbit mandibles. , 2006, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[40]  Eben Alsberg,et al.  Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis. , 2009, Journal of biomedical materials research. Part A.

[41]  R. Ogawa,et al.  Mechanotransduction in bone repair and regeneration , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Antonios G Mikos,et al.  Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. , 2010, Acta biomaterialia.

[43]  Hasan Uludağ,et al.  Nanoparticulate Systems for Growth Factor Delivery , 2009, Pharmaceutical Research.

[44]  J. Aronson Experimental and clinical experience with distraction osteogenesis. , 1994, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[45]  M. Prato,et al.  Biomedical applications of functionalised carbon nanotubes. , 2005, Chemical communications.

[46]  P. Pinton,et al.  Nanotechnology to drive stem cell commitment. , 2013, Nanomedicine.

[47]  B. de Crombrugghe,et al.  Positive Regulation of Adult Bone Formation by Osteoblast‐Specific Transcription Factor Osterix , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  Heungsoo Shin,et al.  Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. , 2007, Advanced drug delivery reviews.

[49]  M. McKee,et al.  Managing Bone Defects , 2011, Journal of orthopaedic trauma.

[50]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[51]  M. Tabrizian,et al.  A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis , 2010, Growth factors.

[52]  Manjusri Misra,et al.  Mechanical properties of carbon nanotubes and their polymer nanocomposites. , 2005, Journal of nanoscience and nanotechnology.

[53]  Min Zhang,et al.  Toward delivery of multiple growth factors in tissue engineering. , 2010, Biomaterials.

[54]  R. St-Arnaud,et al.  Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. , 2008, Bone.

[55]  A. Angelucci,et al.  Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. , 2010, Current cancer drug targets.

[56]  Joseph P Vacanti,et al.  In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. , 2004, Tissue engineering.

[57]  Peter X Ma,et al.  Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. , 2003, Journal of biomedical materials research. Part A.

[58]  Peter X Ma,et al.  Biomimetic nanofibrous scaffolds for bone tissue engineering. , 2011, Biomaterials.

[59]  C. Laurencin,et al.  Nanostructured Polymeric Scaffolds for Orthopaedic Regenerative Engineering , 2012, IEEE Transactions on NanoBioscience.

[60]  J. Jansen,et al.  Local delivery of small and large biomolecules in craniomaxillofacial bone. , 2012, Advanced drug delivery reviews.

[61]  Woo-Sik Kim,et al.  Surface-functionalized nanoparticles for controlled drug delivery. , 2005, Methods in molecular biology.

[62]  M. Tabrizian,et al.  Immunohistochemical Localization of Bone Morphogenetic Protein-signaling Smads during Long-bone Distraction Osteogenesis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[63]  Cato T. Laurencin,et al.  Nanostructured Scaffolds for Bone Tissue Engineering , 2011 .

[64]  Eleftherios Tsiridis,et al.  Bone substitutes: an update. , 2005, Injury.

[65]  K. Yokogawa,et al.  Selective drug delivery to bone using acidic oligopeptides , 2008, Journal of Bone and Mineral Metabolism.

[66]  Chaoliang He,et al.  Nano-composite of poly(L-lactide) and surface grafted hydroxyapatite: mechanical properties and biocompatibility. , 2005, Biomaterials.

[67]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[68]  J. Birch,et al.  Use of the Ilizarov Method to Correct Lower Limb Deformities in Children and Adolescents , 2004, The Journal of the American Academy of Orthopaedic Surgeons.

[69]  G. Cierny,et al.  Segmental tibial defects. Comparing conventional and Ilizarov methodologies. , 1994, Clinical orthopaedics and related research.

[70]  A. Almeida,et al.  Solid lipid nanoparticles as a drug delivery system for peptides and proteins. , 2007, Advanced drug delivery reviews.

[71]  Maryam Tabrizian,et al.  Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. , 2008, Biomaterials.

[72]  T. Webster,et al.  Nanotechnology controlled drug delivery for treating bone diseases , 2009, Expert opinion on drug delivery.

[73]  M. Innocenti,et al.  New biomaterials for bone regeneration. , 2011, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[74]  G. Nienhaus,et al.  Engineered nanoparticles interacting with cells: size matters , 2014, Journal of Nanobiotechnology.

[75]  Georg N Duda,et al.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. , 2012, Advanced drug delivery reviews.

[76]  Francesca Ungaro,et al.  Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.

[77]  L. Cheung,et al.  Treatment of irradiated mandibles with mesenchymal stem cells transfected with bone morphogenetic protein 2/7. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[78]  B. Zeng,et al.  Osteogenic differentiation effects on rat bone marrow-derived mesenchymal stromal cells by lentivirus-mediated co-transfection of human BMP2 gene and VEGF165 gene , 2008, Biotechnology Letters.

[79]  D. Mahapatra,et al.  Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis. , 2013, Journal of biomedical nanotechnology.

[80]  K. Fung,et al.  Expression of Basic Fibroblast Growth Factor During Distraction Osteogenesis , 2001, Clinical orthopaedics and related research.

[81]  V. Hasırcı,et al.  Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.

[82]  V. Rosen,et al.  Are Endogenous BMPs Necessary for Bone Healing during Distraction Osteogenesis? , 2009, Clinical orthopaedics and related research.

[83]  S. Ozturk,et al.  Biomechanical Analysis of the Effect of Mesenchymal Stem Cells on Mandibular Distraction Osteogenesis , 2013, The Journal of craniofacial surgery.

[84]  K. Sairyo,et al.  Continuous local infusion of fibroblast growth factor-2 enhances consolidation of the bone segment lengthened by distraction osteogenesis in rabbit experiment. , 2008, Bone.

[85]  F. Rauch,et al.  Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. , 2003, Plastic and reconstructive surgery.

[86]  C. Simon,et al.  Strong and bioactive composites containing nano-silica-fused whiskers for bone repair. , 2004, Biomaterials.

[87]  John C. Lee,et al.  Co-transfection with the osteogenic protein (OP)-1 gene and the insulin-like growth factor (IGF)-I gene enhanced osteoblastic cell differentiation. , 2006, Biochimica et biophysica acta.

[88]  M. Tabrizian,et al.  Early injection of OP-1 during distraction osteogenesis accelerates new bone formation in rabbits , 2006, Growth factors.

[89]  N Maffulli,et al.  A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbits. , 1999, British journal of plastic surgery.

[90]  Rozalia Dimitriou,et al.  Bone regeneration: current concepts and future directions , 2011, BMC medicine.

[91]  J. Jansen,et al.  Effects of implant surface coatings and composition on bone integration: a systematic review. , 2009, Clinical oral implants research.

[92]  Peter X Ma,et al.  Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. , 2007, Biomaterials.

[93]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[94]  P. McCarron,et al.  Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. , 2008, Journal of biomedical materials research. Part A.

[95]  Y. Kim,et al.  Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. , 2008, Small.

[96]  G. Balasundaram Nanomaterials for Better Orthopedics , 2007 .

[97]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[98]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[99]  Brendon M. Baker,et al.  Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.

[100]  R. Tibshirani,et al.  Complications of use of the Ilizarov technique in the correction of limb deformities in children. , 1993, The Journal of bone and joint surgery. American volume.

[101]  M. Tabrizian,et al.  Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery , 2010, Expert opinion on drug delivery.

[102]  Xudong Yuan,et al.  Recent advances of siRNA delivery by nanoparticles , 2011, Expert opinion on drug delivery.

[103]  Thomas J. Webster,et al.  Nanotechnology for the regeneration of hard and soft tissues , 2007 .

[104]  Jae Woo Park,et al.  The Bone Regenerative Effect of Chitosan Microsphere-Encapsulated Growth Hormone on Bony Consolidation in Mandibular Distraction Osteogenesis in a Dog Model , 2004, The Journal of craniofacial surgery.

[105]  P. Couvreur,et al.  Nano- and microparticles for the delivery of polypeptides and proteins , 1993 .

[106]  Lingzhou Zhao,et al.  The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. , 2010, Biomaterials.

[107]  Laura A. Smith,et al.  The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding. , 2010, Biomaterials.

[108]  Casey K Chan,et al.  Biomimetic nanocomposites for bone graft applications. , 2006, Nanomedicine.

[109]  F. Kloss,et al.  Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes , 2003, Gene Therapy.

[110]  K. Park,et al.  Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[111]  T. Murakami,et al.  Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. , 2003, Journal of biomedical materials research. Part A.

[112]  Thommey P. Thomas,et al.  Dendrimer-epidermal growth factor conjugate displays superagonist activity. , 2008, Biomacromolecules.

[113]  Dik van de Meent,et al.  Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type , 2014, Environmental toxicology and chemistry.

[114]  Ivan Wall,et al.  Administration of growth factors for bone regeneration. , 2012, Regenerative medicine.

[115]  F. He,et al.  A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy , 2012, Nature Medicine.

[116]  A. Mikos,et al.  TGF-&bgr;1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function , 2001, The Journal of bone and joint surgery. American volume.

[117]  Peter X Ma,et al.  Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. , 2004, Biomaterials.

[118]  P. Ma,et al.  Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. , 2009, Biomaterials.

[119]  M. Bostrom,et al.  Combination of Growth Factors Inhibits Bone Ingrowth in the Bone Harvest Chamber , 2001, Clinical orthopaedics and related research.

[120]  P. Moffatt,et al.  Spatial and Temporal Localization of WNT Signaling Proteins in a Mouse Model of Distraction Osteogenesis , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[121]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[122]  Qixin Zheng,et al.  Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous β-TCP ceramic scaffolds , 2006, Biomedical materials.

[123]  Chengtie Wu,et al.  Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration , 2013, International journal of nanomedicine.

[124]  Cato T Laurencin,et al.  Tissue engineering of bone: material and matrix considerations. , 2008, The Journal of bone and joint surgery. American volume.

[125]  Xiaowen Jiang,et al.  Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit tibia. , 2011, Injury.

[126]  A. Salgado,et al.  Nano- and micro-fiber combined scaffolds: A new architecture for bone tissue engineering , 2005, Journal of materials science. Materials in medicine.

[127]  H. Fischer,et al.  Scaffolds for bone healing: concepts, materials and evidence. , 2011, Injury.

[128]  K. Weise,et al.  Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. , 1999, International orthopaedics.

[129]  D. Tasis,et al.  Carbon nanotube–polymer composites: Chemistry, processing, mechanical and electrical properties , 2010 .

[130]  A. Khademhosseini,et al.  DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cells. , 2008, Journal of biomedical materials research. Part A.

[131]  A. Reddi,et al.  Acceleration of Regenerate Ossification During Distraction Osteogenesis with Recombinant Human Bone Morphogenetic Protein-7 , 2003, The Journal of bone and joint surgery. American volume.

[132]  S. Vengallatore,et al.  Nanotechnology and Bone Healing , 2010, Journal of orthopaedic trauma.

[133]  F. Tamimi,et al.  Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[134]  S. Parveen,et al.  Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[135]  M. Tabrizian,et al.  Biocompatibility and safety of a hybrid core-shell nanoparticulate OP-1 delivery system intramuscularly administered in rats. , 2010, Biomaterials.

[136]  D. Mooney,et al.  Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.

[137]  K. Cheung,et al.  Mechanical interlocking with precisely controlled nano- and microscale geometries for implantable microdevices , 2000, 1st Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine and Biology. Proceedings (Cat. No.00EX451).

[138]  Eldridge Jc,et al.  Problems with substantial limb lengthening. , 1991 .

[139]  M. Rouabhia,et al.  Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation. , 2010, Archives of oral biology.

[140]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[141]  J. G. Eley,et al.  Preparation and release characteristics of insulin and insulin-like growth factor-one from polymer nanoparticles , 2007, Journal of microencapsulation.

[142]  Sung‐Wook Choi,et al.  Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. , 2007, Journal of controlled release : official journal of the Controlled Release Society.